|
|
||||||||

* Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, CA 94143; and
Departments of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305
CD8+ cells from HIV-infected individuals showing the CD8+ cell noncytotoxic antiviral response unexpectedly revealed mRNA for VCAM-1, a cell surface molecule found on endothelial cells. Uninfected subjects had undetectable levels of VCAM-1 mRNA in their CD8+ cells. Flow cytometry analysis showed that up to 12% of the CD8+ cells from HIV-positive individuals expressed VCAM-1 compared with 0.8% of the CD8+ cells of HIV-negative individuals. Enrichment of the CD8+VCAM-1+ cell population and subsequent coculture with CD4+ cells acutely infected with HIV-1 showed that the VCAM-1+CD8+ cells were able to suppress viral replication with 50% less input cells than the unseparated CD8+ cell population. This study demonstrates, for the first time, the expression of VCAM-1 on CD8+ cells. Moreover, the CD8+VCAM-1+ cells show enhanced CD8+ cell noncytotoxic antiviral response activity that could have clinical importance in HIV infection.
This article has been cited by other articles:
![]() |
J. E. Leigh, K. M. McNulty, and P. L. Fidel Jr. Characterization of the Immune Status of CD8+ T Cells in Oral Lesions of Human Immunodeficiency Virus-Infected Persons with Oropharyngeal Candidiasis Clin. Vaccine Immunol., June 1, 2006; 13(6): 678 - 683. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |